Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to cut teen suicide events in half

NCT ID NCT05748730

Disease control Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a program called iCHART, designed to help teens aged 12-18 who have depression or suicidal thoughts. The program connects them to mental health care and safety planning. Researchers hope it will reduce suicide-related events by 50% compared to usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 900 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * YOUTH * Youth will be age 12-18 and speak English. * Youth will have current depression or suicidal behavior. Suicidal behavior for iCHART (N=900) is defined as past suicidal thoughts in the past two weeks as indicated by PHQ-9M item #9 ≥ 1, and/or past month suicidal thoughts, and/or prior history of attempt as indicated by items on the PHQ-9M; and 300 who screen positive for depression (PHQ-9M ≥ "11") * 50% of the 300 youth with PHQ-9M ≥ "11" will also be positive for suicide risk as defined for iCHART. * CAREGIVERS/PARENTS * Parents/caregivers of youth in the study must be at least 18 years old and their child must be willing to participate in the study. Caregivers/parents must be able to speak English. Parents are considered biological/adoptive parents or have court documentation that they can provide consent for research as a legal guardian of a youth. Only 1 parent/caregiver will be engaged in research, but in case 1 parent is unavailable, the other may be engaged (meaning it doesn't have to be the same parent participating in assessments/interviews throughout youth study participation). Exclusion Criteria: * YOUTH * Exclusion criteria include conditions that might impair their ability to effectively deploy ETUDES interventions, including: * current manic or psychotic episode, presence of a life-threatening medical condition requiring immediate treatment, intellectual or developmental disability precluding comprehension of study procedure. The latter will will be assessed by parental report of placement in self-contained Special Education classes, EHR review, and during the consent/assent and/or baseline to determine if the participant is not understanding research procedures. * Participants without access to a phone and/or tablet to interact with components of the intervention that require a phone will be excluded. * CAREGIVERS/PARENTS * There are no specific exclusion criteria for caregivers and providers. However, as mentioned in the inclusion criteria, caregivers will be excluded if they are not the biological parent or court-appointed guardian of the youth being interviewed.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Adolescent Behavior Depression depressive disorder Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent behavior Suicide and depression

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Berks Community Health Center

    RECRUITING

    Reading, Pennsylvania, 19604, United States

  • CHOP Primary Care, CHOP Campus

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • CHOP Primary Care, Cobbs Creek

    RECRUITING

    Philadelphia, Pennsylvania, 19139, United States

  • CHOP Primary Care, West Chester

    RECRUITING

    West Chester, Pennsylvania, 19380, United States

  • Children's Community Pediatrics (CCP) of Children's Hospital of Pittsburgh UPMC

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • Conemaugh Memorial Medical Center-Family Medicine

    RECRUITING

    Johnstown, Pennsylvania, 15905, United States

  • Gibbsboro

    RECRUITING

    Gibbsboro, New Jersey, 08026, United States

  • Karabots

    RECRUITING

    Philadelphia, Pennsylvania, 19139, United States

  • Kids Plus Pediatrics (KPP)

    RECRUITING

    Pittsburgh, Pennsylvania, 15217, United States

  • Roxborough

    RECRUITING

    Philadelphia, Pennsylvania, 19128, United States

  • Springfield

    RECRUITING

    Springfield, Pennsylvania, 19064, United States

  • UPMC Center for Adolescent and Young Adult Health

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • UPMC Family Medicine

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.